Virological response and safety of 24‐week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b-Reference-Cited by-同舟云学术

Virological response and safety of 24‐week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b

Published:2012-07-13 Issue:3 Volume:20 Page:167-173
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Toyota J.¹,Ozeki I.¹,Karino Y.¹,Asahina Y.²,Izumi N.²,Takahashi S.³,Kawakami Y.³,Chayama K.³,Kamiya N.⁴,Aoki K.⁴,Yamada I.⁴,Suzuki Y.⁵,Suzuki F.⁵,Kumada H.⁵

Affiliation:

1. Department of Gastroenterology, Sapporo Kosei General Hospital, Hokkaido, Japan

2. Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

3. Division of Frontier Medical Science, Department of Medical and Molecular Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan

4. Research and Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan

5. Department of Hepatology, Toranomon Hospital, Tokyo, Japan

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2893.2012.01640.x

Reference28 articles.

1. World Health Organization.Fact sheet No.164 June 2011 Hepatitis C. Available at:http://www.who.int/mediacentre/factsheets/fs164/en/index.html(accessed 27 June 2011).

2. Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

3. Telaprevir for Retreatment of HCV Infection

4. Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

5. Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy of Daclatasvir Plus Asunaprevir Combination Therapy with Chronic Hepatitis;Hepatitis C Virus Treatment;2016-11-02

2. Resistance-associated mutations to HCV protease inhibitors naturally pre-existed in HIV/HCV coinfected, treatment-naïve patients;Clinics and Research in Hepatology and Gastroenterology;2016-11

3. Cutaneous side-effects of antihepatitis C treatment: the U.K. experience;British Journal of Dermatology;2014-11-30

4. Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions;Hepatology Research;2014-10-15

5. Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner;Antiviral Research;2014-09